Historical position

The Vanguard Group, Inc.’s Tenet Healthcare Corp (THC) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

The Vanguard Group, Inc.Verified through Q4 2025
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2014Earliest verified positive filing snapshot
Latest statusHistorical positionBased on the latest supported relationship state
Peak shares12.43MHighest verified quarter-end share count
Quarters reported13Verified quarters with shares above zero
What happened?

The Vanguard Group, Inc. first reported Tenet Healthcare Corp in Q3 2014. The reported position was increased and reduced across later filings. Verified positive position history runs through Q2 2025. The current relationship status cannot be determined reliably from supported data.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2025
Sold 4.6% of the position−455.24K shares · 9.46M shares remained
Filing context

Quarter-end price $176.00

Q4 2024
Sold 0.5% of the position−47.63K shares · 10.07M shares remained
Filing context

Quarter-end price $126.23

Q3 2024
Sold 2.5% of the position−254.79K shares · 10.12M shares remained
Filing context

Quarter-end price $166.20

Q2 2024
Sold 4.7% of the position−510.65K shares · 10.38M shares remained
Filing context

Quarter-end price $133.03

Q1 2024
Sold 2.0% of the position−222.53K shares · 10.89M shares remained
Filing context

Quarter-end price $105.11

Q3 2023
Bought 0.6% more+63.25K shares · 10.94M shares reported after the change
Filing context

Quarter-end price $65.89

Portfolio importance

How important was Tenet Healthcare Corp in The Vanguard Group, Inc.’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.0%Q2 2025
Last reported rank#522Rank unavailable
Peak portfolio weight0.0%Q3 2014
Best historical rank#515Q3 2024
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$256.442026-09-23

Market context only; not an investor transaction price.

Latest filing quarter-end price$176.00Q2 2025

Derived from validated reported value and shares where supported.

Latest verified investor filingQ4 2025 · filed 2026-01-29
Open SEC filing ↗

Coverage is bounded to Vanguard’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Vanguard’s complete global assets, fund-by-fund ownership, exact trade dates or execution prices.